Clean Science posts record 46% EBITDA margin

Clean Science and Technology Limited reported standalone revenue of INR217 crores in Q1 FY26, down 9% sequentially, but achieved a record EBITDA margin of over 46%. Consolidated sales rose 8% year-on-year to INR240 crores with 42% EBITDA margin.

The company invested INR80 crores in subsidiary Clean Fino-Chem Limited. Performance Chemical 1 is set for Q2 commercialization, while DHDT pharma intermediate is already commercialized with customer samples distributed.

Clean Science plans to launch advanced HALS grades priced at $11-$35 per kg over the next two quarters, targeting a $1.7 billion addressable market expansion.